Pneumococcus and the Brooklyn connection

American Journal of Medicine

Volumn 107, Issue 1 A, 1999, Pages 2-6

  Austrian, Robert ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ISOLATION; CONFERENCE PAPER; LABORATORY TEST; PLEURISY; PNEUMONIA; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0033606815     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(99)00108-4     Document Type: Conference Paper

References (37)

1. Sternberg G.M. A fatal form of septicaemia in the rabbit, produced by the subcutaneous injection of human saliva. An experimental research. Natl Bd of Health Bull. 2:1881;781-783.
2. Ruffer M.A. Remarks on the histology and pathology of Egyptian mummies. Ruffer M.A. Studies in the Paleopathology of Egypt. 1921;11-17 University of Chicago Press, Chicago.
3. Laennec R.T.H. De l'auscultation médiate ou traité du diagnostic de maladies des poumons et du coeur, fondé principalement sur ce nouveau moyen d'exploration. 1819;Brosson JA et Chaudé Libraires, Paris.
4. Townsend C.W., Coolidge A. Jr. The mortality of acute lobar pneumonia. From a study of all the cases of this disease treated at the Massachusetts General Hospital from the first case in 1822 up to the present day. Trans Am Climatol Assoc. 6:1889;22-46.
5. Redtenbacher W. Beobachtungen am Harne bei Lungentzündungen. Zeitschr kais kön Gesellschaft Aertze Wien. 6:1850;373-375.
6. Pasteur L. Note sur la maladie nouvelle provoqué par la salive d'un enfant mort de la rage. Bull Acad Méd (Paris). 10:1881;94-103.
7. Friedländer C. Ueber die Schizomyceten der acuten fibrösen Pneumonie. Virchows Arch Pathol Anat Physiol. 87:1882;319-324.
8. Weichselbaum A. Ueber die Aetiologie der acuten Lüngen-und Rippenfellentzündungen. Med Jahrbüch. 1:1886;483-554.
9. Eggerth AH. The History of the Hoagland Laboratory. Brooklyn, NY, 1960.
10. Schroeder W. History of the Medical Society of the County of Kings. Official Program of the Graeco-Roman Festival to Asklepios and Aesculapius. 1899;Borough of Brooklyn Record Press, Brooklyn, NY.
11. Sternberg G.M. Bacillus diphtheriae (Loeffler). Brooklyn Med J. 3:1889;145-153.
12. Sternberg G.M. Disinfection. Brooklyn Med J. 3:1889;337-349.
13. Avery O.T., Lyall H.W. Concerning secondary infection in pulmonary tuberculosis. J Med Res. 28:1913;111-139.
14. Dubos R. The Professor, the Institute and DNA. 1976;The Rockefeller University Press, New York.
15. White B. The Biology of Pneumococcus. 1938;The Commonwealth Fund, New York.
16. Heffron R. Pneumonia with Special References to Pneumococcus Lobar Pneumonia. 1939;The Commonwealth Fund, New York.
17. Sternberg G.M. Investigations relating to the etiology and prophylaxis of yellow fever. Brooklyn Med J. 2:1888;257-259.
18. Sternberg G.M. Glanders. Brooklyn Med J. 3:1889;63-64.
19. Elfstrom C.E. A form of serum treatment of pneumonia. Brooklyn Med J. 14:1900;603-608.
20. Cornwall E.E. Some don'ts in the treatment of pneumonia. Long Island Med J. 24:1930;25.
21. Cross F.B. Numoquin-base treatment of lobar pneumonia. Long Island Med J. 21:1927;132-133.
22. Morgenroth J., Kaufmann M. Arzneifestigkeit bei Bakterien (Pneumokokken). Zeitschr Immunitätsforsch. 15:1912;610-624.
23. Moore H.F., Chesney A.M. A study of ethylhydrocuprein (Optochin) in the treatment of acute lobar pneumonia. Arch Intern Med. 19:1917;611-682.
24. Lohman W.H., Bogue R.M. Treatment of pneumonia with sulfapyridine. Brooklyn Hosp J. 1:1931;121-136.
25. Baker C.J., Naumer H. The treatment of pneumonia in infants and children with sulfapyridine. A report of 53 cases. Brooklyn Hosp J. 1:1939;217-221.
26. Lohman W.H., Clark D.W. The present status of serum treatment of pneumonia. Brooklyn Hosp J. 1:1939;23-32.
27. Tillett W.S., Cambier M.J., McCormack J.E. The treatment of lobar pneumonia and pneumococcal empyema with penicillin. Bull NY Acad Med. 20:1944;142-178.
28. Reiman H.A. The changing nature of pneumonia. Ann Intern Med. 33:1950;1246-1253.
29. Rhoads P.S. Pneumonia in the aged. Med Clin North Am. 40:1956;89-96.
30. Bridge R.G. The value of bacteriological studies in pneumonia occurring in the age group 15-60. Dis Chest. 30:1956;194-201.
31. Austrian R., Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med. 60:1964;759-776.
32. Sternberg G.M. Induced septicaemia in the rabbit. Am J Med Sci. 84:1882;69-76.
33. Austrian R. Of gold and pneumococci. Trans Am Clin Climat Assoc. 89:1977;141-161.
34. Schiemann O., Casper W. Sind die spezifisch präcipitabelen Substanzen der 3 Pneumokokkentypen Haptene? Zeitschr Hyg Infëktionskr. 108:1927;220-257.
35. Francis T. Jr, Tillett W.S. Cutaneous reactions in pneumonia. The development of antibodies following the intradermal injection of type-specific polysaccharide. J Exp Med. 52:1930;853-865.
36. MacLeod C.M., Hodges R., Heidelberger M., Bernhard W.G. Prevention of pneumococcal pneumonia by immunization. J Exp Med. 82:1945;445-465.
37. Austrian R., Douglas R.M., Schiffman G., et al. Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians. 89:1976;184-194.